Registration of Tobacco, Coffee and Substance Use Among Acutely Admitted Psychiatric Patients

This is a study of the registration of tobacco, coffee and substance abuse among acutely admitted psychiatric patients.

Completed

Looking for future studies?

Key information

Conditions

Substance Abuse Behavior Chemically-Induced Disorders Health Behavior Mental Disorders Substance-Related Disorders Tobacco Use Cessation Tobacco Use Disorder

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Østmarka Psychiatric Department, St. Olavs Hospital, University Hospital of Trondheim

Trondheim, Norway

About this study

We will include all patients acutely admitted to Østmarka Psychiatric Hospital to register this population's use of coffee, tobacco and substances. We will determine whether this differs from other populations, between diagnoses, age, etc.

We will also compare results of substance in immunologic rapid urine tests taken by the nurse at the hospital with substance in urine tested in laboratory with LC/MS (liquid chromatography/mass spectrometry).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All patients acutely admitted to Østmarka Psychiatric Hospital

Exclusion criteria

Dementia
Serious brain damage

Sponsors and collaborators

Lead sponsor

Norwegian University of Science and Technology

Other

Collaborators

St. Olavs Hospital

Registry information

Important dates

Study start: 2004
Primary completion: 2005
Study completion: 2005
First posted: Sep 16, 2005
Registry last updated: Mar 14, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed